• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (IRVINE) XEN 45 GTS; IMPLANT, EYE VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (IRVINE) XEN 45 GTS; IMPLANT, EYE VALVE Back to Search Results
Catalog Number 5513-001
Device Problem Defective Component (2292)
Patient Problem No Patient Involvement (2645)
Event Date 06/04/2019
Event Type  malfunction  
Manufacturer Narrative
A review of the device history record has been initiated.If any deviations or non-conformance's are found, a supplemental medwatch will be submitted.Serial number (b)(4), lot number 62578.Device labeling: precautions: the xen®45 gel stent and xen® injector should be carefully examined in the operating room prior to use.
 
Event Description
Healthcare professional reported needle (retracting part of the needle) and gel stent are shorter than specification against the xen®45 gts.Surgery was completed with another xen.There was no patient contact, hence no eye injury.
 
Manufacturer Narrative
A review of the device history record has been completed.No deviations or non-conformances noted.Device evaluation: the needle was not able to sufficiently straighten and unable to be tested for actuation.The gel stent received was crinkled in the dry state.The implant was hydrated and there was no obstruction in the inner channel of the implant.The hydrated implant was measured to be within specification.The gel stent was crinkled in the dry stated, but once the implant was hydrated there were no issues with the gel stent.The initial condition of the implant suggest that the injector was actuated while the retention plug was still in the needle.The manufactured xen systems are 100% tested in-process and inspected at manufacturing.Allergan will continue to monitor the frequency of these complaints to determine if there is a trend or if this was an individual occurrence.
 
Event Description
Healthcare professional reported needle (retracting part of the needle) and gel stent are shorter than specification against the xen®45 gts.Surgery was completed with another xen.There was no patient contact, hence no eye injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XEN 45 GTS
Type of Device
IMPLANT, EYE VALVE
Manufacturer (Section D)
ALLERGAN (IRVINE)
2525 dupont drive
irvine CA 92612
MDR Report Key8756030
MDR Text Key149930396
Report Number3011299751-2019-00139
Device Sequence Number1
Product Code KYF
Combination Product (y/n)N
PMA/PMN Number
K161457
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 09/13/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/02/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2021
Device Catalogue Number5513-001
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/17/2019
Date Manufacturer Received08/27/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-